ICER To Conduct Review Of Buprenorphine Treatments

The Institute for Clinical and Economic Review (ICER) is seeking input from stakeholders about the clinical effectiveness and value of certain buprenorphine treatments for opioid use disorder, including a recently FDA-approved buprenorphine injection, a buprenorphine implant and an investigational buprenorphine extended-release injection currently under FDA review, and how they compare to other commonly used medication-assisted treatment (MAT) drugs, the group announced Thursday (April 5). FDA has touted its support for widespread and safe use of MAT to treat opioid use...